Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment

Kali Therapeutics said on Monday it has entered into a licensing agreement with French drugmaker Sanofi to ​develop the privately held firm's experimental treatment for ‌several autoimmune diseases.